---
figid: PMC9221492__cancers-14-02837-g001
pmcid: PMC9221492
image_filename: cancers-14-02837-g001.jpg
figure_link: /pmc/articles/PMC9221492/figure/cancers-14-02837-f001/
number: Figure 1
figure_title: ''
caption: KRAS downstream effector pathways. The active form of KRAS (KRAS-GTP) regulates
  many signaling pathways affecting essential cellular functions such as cell proliferation,
  migration, survival, differentiation, endocytosis, migration and angiogenesis through
  the interaction with different effectors. Adapted from Soriano et al. []. Further
  detail regarding therapeutic approaches is provided in . Figure made in https://biorender.com
  (accessed on 31 May 2022).
article_title: Synthetic Vulnerabilities in the KRAS Pathway.
citation: Marta Roman, et al. Cancers (Basel). 2022 Jun;14(12):2837.
year: '2022'

doi: 10.3390/cancers14122837
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: MDPI

keywords:
- KRAS
- cancer
- synthetic lethality

---
